Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Rajkumar

Showing results (61-70 of 172) with videos related to

Pageof 18
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 11, 1998
Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade gliomaS V Rajkumar, J C Buckner, P J Schomberg, et al.
Neurosurgery|January 23, 1999
Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomasS V Rajkumar, J C Buckner, P J Schomberg, et al.
Leukemia|September 27, 2003
Expression of VEGF and its receptors by myeloma cellsS Kumar, T E Witzig, M Timm, et al.
Blood Cancer Journal|October 27, 2015
Characteristics of exceptional responders to lenalidomide-based therapy in multiple myelomaT Vu, W Gonsalves, S Kumar, et al.
Bone Marrow Transplantation|December 14, 2011
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significanceG V Manson, E Campagnaro, A Balog, et al.
Leukemia|August 21, 2012
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaG Bianchi, R A Kyle, D R Larson, et al.
Leukemia|August 26, 2006
Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myelomaM M Timm, T K Kimlinger, J L Haug, et al.
New York State Journal of Medicine|July 1, 1977
Cardiopulmonary resuscitation: assessing emergency department staff performanceR M Russo, T A Laude, K A Sheth, et al.
Seminars in Oncology|April 30, 2003
Long-term follow-up of IgM monoclonal gammopathy of undetermined significanceR A Kyle, T M Therneau, S V Rajkumar, et al.
Blood Cancer Journal|September 10, 2013
Pomalidomide: the new immunomodulatory agent for the treatment of multiple myelomaA A Chanan-Khan, A Swaika, A Paulus, et al.
Pageof 18

Showing results (61-70 of 172) with videos related to

Sort By:
Pageof 18
International Journal of Radiation Oncology, Biology, Physics|February 11, 1998
Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade gliomaS V Rajkumar, J C Buckner, P J Schomberg, et al.
Neurosurgery|January 23, 1999
Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomasS V Rajkumar, J C Buckner, P J Schomberg, et al.
Leukemia|September 27, 2003
Expression of VEGF and its receptors by myeloma cellsS Kumar, T E Witzig, M Timm, et al.
Blood Cancer Journal|October 27, 2015
Characteristics of exceptional responders to lenalidomide-based therapy in multiple myelomaT Vu, W Gonsalves, S Kumar, et al.
Bone Marrow Transplantation|December 14, 2011
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significanceG V Manson, E Campagnaro, A Balog, et al.
Leukemia|August 21, 2012
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaG Bianchi, R A Kyle, D R Larson, et al.
Leukemia|August 26, 2006
Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myelomaM M Timm, T K Kimlinger, J L Haug, et al.
New York State Journal of Medicine|July 1, 1977
Cardiopulmonary resuscitation: assessing emergency department staff performanceR M Russo, T A Laude, K A Sheth, et al.
Seminars in Oncology|April 30, 2003
Long-term follow-up of IgM monoclonal gammopathy of undetermined significanceR A Kyle, T M Therneau, S V Rajkumar, et al.
Blood Cancer Journal|September 10, 2013
Pomalidomide: the new immunomodulatory agent for the treatment of multiple myelomaA A Chanan-Khan, A Swaika, A Paulus, et al.
Pageof 18